Trilogy Capital Inc. Bristol Myers Squibb CO Transaction History
Trilogy Capital Inc.
- $1.92 Billion
- Q3 2024
A detailed history of Trilogy Capital Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trilogy Capital Inc. holds 66,122 shares of BMY stock, worth $3.89 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
66,122
Previous 65,703
0.64%
Holding current value
$3.89 Million
Previous $2.73 Million
25.4%
% of portfolio
0.18%
Previous 0.15%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.34 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.47 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.59 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.59 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...